Albert James Chang
استاد بالینی · Radiation Oncology
University of California, Los Angelesمعرفی
Albert James Chang is a Professor of Clinical in both Radiation Oncology and Urology at the University of California Los Angeles (UCLA), where he also serves as Department Vice Chair for Radiation Oncology. His academic career spans over two decades with significant contributions to the field of radiation oncology, particularly in prostate cancer treatment and brachytherapy.
Dr. Chang's research focuses on advanced radiation therapy techniques for various cancers, with particular expertise in prostate cancer, bladder cancer, and lung cancer treatments. His work explores the optimization of brachytherapy, stereotactic body radiation therapy, and multimodal treatment approaches. He has conducted extensive research on treatment outcomes, radiation dosing, and the integration of novel technologies in radiation oncology. His recent publications reveal a strong emphasis on clinical outcomes research, comparative effectiveness studies, and the development of consensus guidelines in radiation oncology, particularly through his work with the American Brachytherapy Society.
- Professor of Clinical, Radiation Oncology, UCLA
- Professor of Clinical, Urology, UCLA
- Department Vice Chair, Radiation Oncology, UCLA
Dr. Chang has been instrumental in mentoring numerous researchers and clinicians in the field of radiation oncology. His collaborative approach is evident through his extensive co-authorship with colleagues across multiple institutions, contributing to the advancement of radiation therapy techniques and their clinical applications. His work on socioeconomic and racial disparities in brachytherapy utilization has highlighted important equity issues in cancer treatment access.
He leads research initiatives focused on improving radiation therapy outcomes, particularly in prostate cancer treatment, where his work on brachytherapy techniques, dose optimization, and combination therapies has been influential in shaping clinical practice guidelines. His research on hydrogel spacers to reduce rectal toxicity during prostate radiation therapy has directly impacted patient care quality.
